• Explore /
  • Poster
  • / The impact of modified Glasgow Prognostic Scale as a predictor of survival advantage by FOLFIRINOX in metastatic pancreatic cancer.

The impact of modified Glasgow Prognostic Scale as a predictor of survival advantage by FOLFIRINOX in metastatic pancreatic cancer.

Abstract Poster

Authors

null

Ikuhiro Yamada

Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

Ikuhiro Yamada , Masato Ozaka , Ryo Kanata , Kei Saito , Takashi Sasaki , Masato Matsuyama , Kouichi Takano , Naoki Sasahira

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 440)

DOI

10.1200/jco.2016.34.4_suppl.440

Abstract #

440

Poster Bd #

M12

Abstract Disclosures

Similar Posters

First Author: Kenneth H. Yu

First Author: Lauren Carcas

First Author: Vincent Chung

First Author: Joon Oh Park